State of Alaska, Department of Revenue - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 194 filers reported holding SAGE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
State of Alaska, Department of Revenue ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$141,000
-6.0%
3,329
-1.9%
0.00%
-50.0%
Q3 2021$150,000
-75.5%
3,395
-68.5%
0.00%
-66.7%
Q2 2021$611,000
+7.2%
10,769
+41.3%
0.01%0.0%
Q1 2021$570,000
-45.3%
7,621
+33.7%
0.01%
-66.7%
Q2 2019$1,043,000
+15.5%
5,700
+0.4%
0.02%
+12.5%
Q1 2019$903,000
+68.5%
5,680
+1.3%
0.02%
+60.0%
Q4 2018$536,000
-31.7%
5,605
+0.7%
0.01%
-23.1%
Q3 2018$785,000
-9.1%
5,564
+0.8%
0.01%
-13.3%
Q2 2018$864,0005,5200.02%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders